Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website
Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website
This is a 25% decrease from the number of companies inspected in the previous quarter, when eight companies received eight inspections.
Most of the companies inspected at the time were involved in the Biologics and Food and Cosmetics sectors. Both the Devices and Veterinary sectors sectors tied for second most common type.
All of the companies were in line with FDA regulations, and don't need to adjust their managing operations or regulatory/administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Blue Sky Fertility Services, LLC | Biologics | 09/06/2023 | No Action Indicated (NAI) |
KC Deli Provisions, Inc. | Food and Cosmetics | 09/21/2023 | No Action Indicated (NAI) |
Reproductive Resource Center of Greater KC, LLC | Biologics | 08/14/2023 | No Action Indicated (NAI) |
The Andersons, Inc. | Veterinary | 09/19/2023 | No Action Indicated (NAI) |
University of Kansas Medical Center | Devices | 07/28/2023 | No Action Indicated (NAI) |
Walmart eCommerce | Food and Cosmetics | 09/18/2023 | No Action Indicated (NAI) |